Regarding neutrophil (CD15+ CD66b+ CD11b+) abundance, no significant differences among ascites- or tumor tissue-derived neutrophils were obvious, with 13.88 ± 5.84% and 10.01 ± 2.54% of CD45+ cells, respectively (Figure 3A). This evidence concerns the gene PTPRC and neoplasm.